Web9 hours ago · Aadi has also initiated PRECISION 1, a Phase 2 tumor-agnostic registration-intended trial in mTOR inhibitor-naïve malignant solid tumors harboring TSC1 or TSC2 inactivating alterations. WebKnockdown of AKT3 in DU-145 cells with siRNAincreased the sensitivity of DU-145 cells to B-Raf inhibitor treatment. Knockdown ofTSC1 or TSC2 promoted the proliferation of PCa cells. Our observations implied thatAKT3 may be a potential therapeutic target for PCa treatment. KW - Akt3. KW - B-Raf. KW - Proliferation. KW - Prostate cancer. KW - TSC1/2
Sapanisertib, a dual mTORC1/2 inhibitor, for TSC1- or
WebApr 14, 2024 · nab-Sirolimus is a novel albumin-bound mTOR inhibitor (mTORi) approved in the US for adult patients with advanced malignant PEComa. Eligible patients are ≥12 years old and mTORi-naïve, possess malignant solid tumors with TSC1 or TSC2 inactivating alterations (confirmed by central review of sequencing reports), and have received … WebHere, we show that TSC1-TSC2 inhibits the p70 ribosomal protein S6 kinase 1 (an activator of translation) and activates the eukaryotic initiation factor 4E binding protein 1 (4E-BP1, … shapes of cats
TSC1 Controls Distribution of Actin Fibers through Its Effect on
WebAug 12, 2002 · Inhibition of S6K by TSC1–TSC2. To elucidate a mechanism of TSC1–TSC2 function in the control of cell growth, we examined the effect of TSC1–TSC2 on S6K … WebMar 21, 2024 · TSC1 (TSC Complex Subunit 1) is a Protein Coding gene. Diseases associated with TSC1 include Tuberous Sclerosis 1 and Lymphangioleiomyomatosis . … WebJul 9, 2010 · The TSC1 and TSC2 gene products form a functional complex that has GTPase-activating protein (GAP) ... is inhibited by TSC1 and 2. Mol Cell 2003; 11: … shapes of cars